表紙
市場調查報告書
商品編碼
694204

生技藥品製造的全球市場:2018年∼2022年

Global Biologics Manufacturing Market 2018-2022

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 114 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

關於生技藥品

生技藥品,生物醫藥品,生物藥品,是指從像人、植物及動物的生物來源的生物材料抽取、合成,及製造的藥物。生技藥品製造變是那種藥物的製造。

Technavio的分析師預測,從2018年到2022年之間,全球生技藥品製造市場將以9.11%的年複合成長率成長。

本報告提供全球生技藥品製造市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模(2017年)
  • 市場規模及預測(2017-2022年)

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 市場區隔:各技術

  • 市場區隔:各技術(2017-2022年)
  • 比較:各技術
  • 裡面制
  • 外包
  • 市場機會:各技術

第8章 市場區隔:各產品

  • 市場區隔:各產品(2017-2022年)
  • 比較:各產品
  • 生技藥品
  • 生物相似藥
  • 市場機會:各產品

第9章 客戶形勢

第10章 地區形勢

  • 各地區市場區隔(2017-2022年)
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 主要國家
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • 傳統的生物醫藥品產業和生物科技的新興企業之間的夥伴關係的增加
  • 生技藥品製造業的外包擴大
  • 新的生物醫藥品的FDA核準增加

第14章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭模式

第15章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer

第16章 附錄

  • 簡稱的清單
目錄
Product Code: IRTNTR23716

About Biologics

Biologics, biopharmaceutical, biologic drugs, or biological drugs refer to drugs that are extracted, synthesized, and manufactured from biological material derived from living sources, such as humans, plants, and animals. Biologics manufacturing refers to the production of such drugs.

Technavio's analysts forecast the Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Biologics Manufacturing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Merck & Co
  • Pfizer

Market driver

  • Introduction of new biologic drugs for treating diseases
  • For a full, detailed list, view our report

Market challenge

  • High cost of branded drugs is deterring market growth
  • For a full, detailed list, view our report

Market trend

  • Rise in partnerships between traditional biopharma companies and biotechnology startups
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY

  • Segmentation by technology
  • Comparison by technology
  • In-house - Market size and forecast 2017-2022
  • Outsourced - Market size and forecast 2017-2022
  • Market opportunity by technology

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Biologics - Market size and forecast 2017-2022
  • Biosimilars - Market size and forecast 2017-2022
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Rise in partnerships between traditional biopharma companies and biotechnology startups
  • Growing outsourcing of biologics manufacturing
  • Increase in FDA approvals for new biologics products

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer

PART 16: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 08: Global - Year-over-year growth 2018-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2017
  • Exhibit 17: Technology - Market share 2017-2022 (%)
  • Exhibit 18: Comparison by technology
  • Exhibit 19: In-house - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 20: In-house - Year-over-year growth 2018-2022 (%)
  • Exhibit 21: Outsourced - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 22: Outsourced - Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Market opportunity by technology
  • Exhibit 24: Product - Market share 2017-2022 (%)
  • Exhibit 25: Comparison by product
  • Exhibit 26: Biologics - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 27: Biologics - Year-over-year growth 2018-2022 (%)
  • Exhibit 28: Biosimilars - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 29: Biosimilars - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Market opportunity by product
  • Exhibit 31: Customer landscape
  • Exhibit 32: Global - Market share by geography 2017-2022 (%)
  • Exhibit 33: Regional comparison
  • Exhibit 34: Americas - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 35: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: EMEA - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 37: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: APAC - Market size and forecast 2017-2022 ($ bn)
  • Exhibit 39: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 40: Key leading countries
  • Exhibit 41: Market opportunity
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Amgen: Overview
  • Exhibit 48: Amgen - Business segments
  • Exhibit 49: Amgen - Organizational developments
  • Exhibit 50: Amgen - Geographic focus
  • Exhibit 51: Amgen - Key offerings
  • Exhibit 52: F. Hoffmann-La Roche: Overview
  • Exhibit 53: F. Hoffmann-La Roche- Business segments
  • Exhibit 54: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 55: F. Hoffmann-La Roche- Geographic focus
  • Exhibit 56: F. Hoffmann-La Roche- Segment focus
  • Exhibit 57: F. Hoffmann-La Roche - Key offerings
  • Exhibit 58: Johnson & Johnson: Overview
  • Exhibit 59: Johnson & Johnson- Business segments
  • Exhibit 60: Johnson & Johnson - Organizational developments
  • Exhibit 61: Johnson & Johnson - Geographic focus
  • Exhibit 62: Johnson & Johnson - Segment focus
  • Exhibit 63: Johnson & Johnson - Key offerings
  • Exhibit 64: Merck & Co.: Overview
  • Exhibit 65: Merck & Co. - Business segments
  • Exhibit 66: Merck & Co. - Organizational developments
  • Exhibit 67: Merck & Co. - Geographic focus
  • Exhibit 68: Merck & Co. - Segment focus
  • Exhibit 69: Merck & Co. - Key offerings
  • Exhibit 70: Pfizer: Overview
  • Exhibit 71: Pfizer - Business segments
  • Exhibit 72: Pfizer - Organizational developments
  • Exhibit 73: Pfizer - Geographic focus
  • Exhibit 74: Pfizer - Segment focus
  • Exhibit 75: Pfizer - Key offerings